Dupont Capital Management Corp raised its stake in Marsh & McLennan Companies, Inc. (NYSE:MMC - Free Report) by 7.0% during the 1st quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 49,071 shares of the financial services provider's stock after purchasing an additional 3,198 shares during the period. Marsh & McLennan Companies accounts for about 1.3% of Dupont Capital Management Corp's holdings, making the stock its 23rd biggest position. Dupont Capital Management Corp's holdings in Marsh & McLennan Companies were worth $11,975,000 as of its most recent filing with the Securities & Exchange Commission.
Several other hedge funds also recently added to or reduced their stakes in MMC. Brighton Jones LLC increased its stake in Marsh & McLennan Companies by 51.2% in the fourth quarter. Brighton Jones LLC now owns 8,738 shares of the financial services provider's stock valued at $1,856,000 after purchasing an additional 2,960 shares during the last quarter. Union Bancaire Privee UBP SA purchased a new position in Marsh & McLennan Companies in the fourth quarter valued at approximately $10,366,000. Bank Pictet & Cie Europe AG purchased a new position in Marsh & McLennan Companies in the fourth quarter valued at approximately $37,178,000. J.W. Cole Advisors Inc. increased its stake in Marsh & McLennan Companies by 38.4% in the fourth quarter. J.W. Cole Advisors Inc. now owns 1,495 shares of the financial services provider's stock valued at $317,000 after purchasing an additional 415 shares during the last quarter. Finally, Atria Wealth Solutions Inc. boosted its holdings in shares of Marsh & McLennan Companies by 5.0% in the fourth quarter. Atria Wealth Solutions Inc. now owns 9,008 shares of the financial services provider's stock valued at $1,913,000 after acquiring an additional 425 shares during the period. 87.99% of the stock is currently owned by hedge funds and other institutional investors.
Insider Buying and Selling at Marsh & McLennan Companies
In other Marsh & McLennan Companies news, CEO Dean Michael Klisura sold 9,569 shares of the firm's stock in a transaction on Monday, March 31st. The stock was sold at an average price of $245.00, for a total value of $2,344,405.00. Following the completion of the sale, the chief executive officer now owns 20,935 shares of the company's stock, valued at approximately $5,129,075. This trade represents a 31.37% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, SVP Paul Beswick sold 2,237 shares of the firm's stock in a transaction on Thursday, April 3rd. The shares were sold at an average price of $246.00, for a total value of $550,302.00. Following the completion of the transaction, the senior vice president now owns 13,522 shares of the company's stock, valued at approximately $3,326,412. This represents a 14.20% decrease in their position. The disclosure for this sale can be found here. 0.35% of the stock is owned by corporate insiders.
Analyst Ratings Changes
Several research firms have recently weighed in on MMC. UBS Group increased their price objective on Marsh & McLennan Companies from $259.00 to $261.00 and gave the company a "buy" rating in a report on Wednesday, April 9th. Redburn Atlantic began coverage on Marsh & McLennan Companies in a report on Tuesday, March 25th. They issued a "buy" rating and a $281.00 price objective for the company. Jefferies Financial Group increased their price objective on Marsh & McLennan Companies from $237.00 to $244.00 and gave the company a "hold" rating in a report on Friday, April 11th. Keefe, Bruyette & Woods decreased their price objective on Marsh & McLennan Companies from $220.00 to $215.00 and set an "underperform" rating for the company in a report on Monday, April 21st. Finally, Wells Fargo & Company increased their price objective on Marsh & McLennan Companies from $223.00 to $232.00 and gave the company an "equal weight" rating in a report on Thursday, April 10th. Two research analysts have rated the stock with a sell rating, seven have given a hold rating and five have issued a buy rating to the company. According to data from MarketBeat, the company has an average rating of "Hold" and an average target price of $241.93.
View Our Latest Stock Analysis on MMC
Marsh & McLennan Companies Stock Performance
Shares of NYSE MMC traded up $2.09 during mid-day trading on Friday, hitting $216.41. 4,677,558 shares of the company were exchanged, compared to its average volume of 1,959,036. The company has a quick ratio of 1.14, a current ratio of 1.14 and a debt-to-equity ratio of 1.32. The stock has a 50 day simple moving average of $225.13 and a 200-day simple moving average of $224.77. Marsh & McLennan Companies, Inc. has a 1-year low of $207.21 and a 1-year high of $248.00. The firm has a market cap of $106.63 billion, a price-to-earnings ratio of 26.52, a price-to-earnings-growth ratio of 2.65 and a beta of 0.83.
Marsh & McLennan Companies (NYSE:MMC - Get Free Report) last issued its quarterly earnings results on Thursday, April 17th. The financial services provider reported $3.06 earnings per share for the quarter, topping the consensus estimate of $3.02 by $0.04. Marsh & McLennan Companies had a return on equity of 32.19% and a net margin of 16.13%. The firm had revenue of $6.70 billion during the quarter, compared to the consensus estimate of $7.08 billion. During the same period last year, the company earned $2.89 earnings per share. On average, sell-side analysts forecast that Marsh & McLennan Companies, Inc. will post 9.61 EPS for the current fiscal year.
Marsh & McLennan Companies Company Profile
(
Free Report)
Marsh & McLennan Cos., Inc is a professional services firm, which engages in offering clients advice and solutions in risk, strategy, and people. It operates through the Risk and Insurance Services, and Consulting segments. The Risk and Insurance Services segment is involved in risk management activities, as well as insurance and reinsurance broking and services.
Featured Articles

Before you consider Marsh & McLennan Companies, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Marsh & McLennan Companies wasn't on the list.
While Marsh & McLennan Companies currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Nuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.